2022 Brings the Latest in Testing and Treatments for Alzheimer’s Disease
July 27, 2022
Alzheimer’s disease gradually destroys memory and other mental functions that cause confusion. Many of us have a friend, family member, or know of someone that has been diagnosed. The medical community continues to search for ways to relieve symptoms, test for early signs, and find a cure.
Studies
have shown that changes in learning and memory happen well before signs of Alzheimer’s are found in brain scans. Early detection could offer an opportunity for preventative treatment in the future.
Testing for Earlier Diagnosis
Recently, The US Food and Drug Administration (FDA) authorized the first in vitro diagnostic for early testing of Alzheimer’s disease. It is an alternative to (PET) scans that use radiation and cerebrospinal fluid taps that are costly and time-consuming.
In May 2022, Fujirebio Diagnostic developed a new testing application for patients 55 years and older who have shown cognitive impairment. The test was able to get through an expedited review process. It can be used to detect brain plaques and analyze spinal fluid and proteins that accumulate to form the amyloid-beta plaques tied to Alzheimer’s disease. The FDA suggests testing be combined with other clinical evaluations to confirm a diagnosis.
In May 2022, Fujirebio Diagnostic developed a new testing application for patients 55 years and older who have shown cognitive impairment. The test was able to get through an expedited review process. It can be used to detect brain plaques and analyze spinal fluid and proteins that accumulate to form the amyloid-beta plaques tied to Alzheimer’s disease. The FDA suggests testing be combined with other clinical evaluations to confirm a diagnosis.
Doctors and medical labs evaluate the future of alzheimer's
Most primary care doctors believe that one day, dementia will be managed as a chronic disease. But that means doctors and patients need to be made aware of new treatments and technologies, like the test developed by Fujirebio Diagnostic.
A survey by the Harris Poll for Quest Diagnostics suggests half of physicians don’t think Alzheimer’s will ever be cured, but about 75% thought new therapies might help manage the disease. Quest introduced a blood test in March for the early detection of Alzheimer’s. The company wants to see physicians and patients begin to prepare for the newer, more convenient diagnostics to become widespread tools in the health care industry. Diagnostic blood tests would be faster and more cost-effective for the healthcare system overall and lead to a more immediate referral to specialists. However, the majority of clinicians also feared the blood tests for Alzheimer’s would cause a surge in diagnoses and stress the health care system.
A survey by the Harris Poll for Quest Diagnostics suggests half of physicians don’t think Alzheimer’s will ever be cured, but about 75% thought new therapies might help manage the disease. Quest introduced a blood test in March for the early detection of Alzheimer’s. The company wants to see physicians and patients begin to prepare for the newer, more convenient diagnostics to become widespread tools in the health care industry. Diagnostic blood tests would be faster and more cost-effective for the healthcare system overall and lead to a more immediate referral to specialists. However, the majority of clinicians also feared the blood tests for Alzheimer’s would cause a surge in diagnoses and stress the health care system.
What next?
If you are concerned about Alzheimer's and dementia and wondering about your planning options, you can:
- Give us a call at 720-821-7604 to schedule a "Discovery Session" at which we can determine whether our firm would be a good fit for your needs. Or fill out our contact form to have us call you.
- Visit our estate planning page to learn more about how proactively thinking through your estate plan can protect you and your family, minimize hassle, lower the chance of family discord, and minimize or eliminate taxes.
- Learn more by reading our blog or watching our videos .
Does having a will make probate faster in Centennial, Colorado? Learn what affects timing and how clear estate planning can help your family prepare.
Can a will expire in Colorado? Learn how older wills remain valid, when to update an estate plan, and how The McKenzie Law Firm, LLC assists Centennial residents.
Losing a loved one is overwhelming, and many families are surprised to learn that financial matters can freeze instantly after a passing. When a person dies, their legal financial identity stops immediately. This means they can no longer hold property, sign agreements, or authorize payments. Even if you hold a power of attorney—a legal document allowing you to make decisions on someone’s behalf while they are alive—that authority ends the moment they pass away. Families across the Denver metro area are often caught off guard when trying to access funds to pay for immediate expenses.
Learn what happens if your main beneficiary can’t inherit your assets and discover the common will mistakes Denver families should avoid to protect their estate.
Discover what happens if a trustee misuses funds in Colorado. Learn about trustee personal liability, legal consequences, and how to protect family trust assets.,
Wondering if you can use a deceased parent’s debit card to pay their final bills? Learn why doing so can cause legal trouble and how proper estate planning helps.
Think writing a will keeps your estate out of court? Learn why a will does not avoid probate in Colorado and how proper planning protects your family’s legacy.
Learn what documents you need for medical incapacity in Colorado, including medical powers of attorney and living wills. Contact The McKenzie Law Firm, LLC today.
Learn how to choose a successor trustee for your Colorado estate plan. Discover key tips to protect your family and manage assets smoothly in the Denver metro area.
Discover why a residuary clause in a will is essential to protect unlisted assets like homes and retirement accounts from probate court in Colorado.